Drugs / encapsulated faecal microbiota
encapsulated faecal microbiota
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT03843385 Comparator | Jan 2023 → Jul 2026 overdue | ulcerative colitis | Andreas Stallmach | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | encapsulated faecal microbiota | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03843385 ↗ |
| Modality | Other / unclassified | “fecal microbiota (FM) transfer (FMT)” PMID 35193638 ↗ Feb 2022 |
| Route | Oral | “using oral, frozen capsules” NCT03843385 ↗ |